The impact of multidisciplinary team conferences in urologic cancer in a tertiary hospital
| Autor: | Luís Campos Pinheiro, Rui Bernardino, João Guerra, Gil Falcão, Mariana Medeiros, Fernando Calais da Silva, Thiago Guimarães, V. Andrade, Miguel Gil |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Male
medicine.medical_specialty Urologic Neoplasms Referral Acceptance rate Urology CHLC URO 030232 urology & nephrology Specialty 030204 cardiovascular system & hematology Multidisciplinary team Tertiary Care Centers 03 medical and health sciences 0302 clinical medicine medicine Humans Practice Patterns Physicians' Testicular cancer Aged Retrospective Studies Aged 80 and over Patient Care Team Bladder cancer business.industry General surgery Congresses as Topic Middle Aged medicine.disease Nephrology Urologic cancer Female Primary tumour site business |
| Zdroj: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) Agência para a Sociedade do Conhecimento (UMIC)-FCT-Sociedade da Informação instacron:RCAAP |
| ISSN: | 1573-2584 |
| Popis: | Purpose: Multidisciplinary team (MDT) conferences are currently the standard of care in cancer patients' management. Despite evidence supporting benefits to the majority of malignancies, a paucity of data exists examining the impact in urinary and male genital cancers. This study aims to evaluate the impact of MDT conferences in urologic cancer practice. Methods: Clinical plans discussed in urologic MDT conferences in Centro Hospitalar Universitário de Lisboa Central between January 2019 and December 2019 were retrospectively analysed. Clinical plans were categorized as accepted, changed, rejected (cases that had to be re-presented to the MDT because of insufficient staging or administrative issues) or no plan. MDT conferences' impact was assessed according to type of consultation, referral medical specialty and primary tumour type. Results: 710 clinical plans were discussed at the MDT conferences. 61.8% were accepted, 10.6% were changed, 16.5% were rejected and 11.1% of cases referred to MDT discussion had no defined clinical plan. First consultations had a higher rate of accepted clinical plans (63.4%) versus subsequent consultations (56.4%). Referrals by the urology specialty had the highest rate of acceptances (64.3%). On the stratification by primary tumour site, testicular cancer had the highest acceptance rate (70.3%), whereas bladder cancer had the lowest (47.8%). Conclusions: MDT conferences had an important impact in the management of 38.2% of cases. Therefore, all patients with urologic malignancies should be referred to MDT review to ensure optimal clinical care. info:eu-repo/semantics/publishedVersion |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink